Class IITerminatedD-0754-2023
Drug recall · May 31, 2023
HyperLyte CR Injection recall
Why: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HyperLyte CR Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-1, code 7128580941.
- Lots / codes
Lot # 37-874236, Exp 06/20/2023; 37-878694, Exp 07/10/2023
- Quantity
- 554 bags
- Company
- Central Admixture Pharmacy Services, Inc., Allentown, PA
- Distribution
- Nationwide in the USA.
- Initiated
- April 28, 2023 · Voluntary: Firm initiated
- Classified
- May 19, 2023
- Reported
- May 31, 2023
- Ended
- June 22, 2025
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedMay 31, 2023MicroplegiaCentral Admixture Pharmacy Services, Inc. · D-0648-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0649-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0650-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0651-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0652-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0653-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0654-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0655-2023Class IITerminatedMay 31, 2023Microplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0656-2023Class IITerminatedMay 31, 2023Transplant SolutionCentral Admixture Pharmacy Services, Inc. · D-0657-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0658-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionCentral Admixture Pharmacy Services, Inc. · D-0659-2023
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.